The present stock price for Recursion Pharmaceuticals Inc (RXRX) is $6.60. In the last trading session, the stock made a considerable jump, reaching $7.23 after an opening price of $7.07. The stock briefly fell to $6.8206 before ending the session at $6.86.
In terms of market performance, Recursion Pharmaceuticals Inc had a fairly uneven. The highest value for the stock in the past year was $16.75 on 07/19/23, and the lowest value was recorded at $4.54 on 05/02/23.
52-week price history of RXRX Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Recursion Pharmaceuticals Inc’s current trading price is -60.59% away from its 52-week high, while its distance from the 52-week low is 45.37%. The stock’s price range during this period has spanned from $4.54 to $16.75. In the Healthcare sector, the Recursion Pharmaceuticals Inc’s shares surpassed a trading volume of approximately 1.71 million for the day, which was noticeably lower compared to the average daily volume of 9.3.72 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Recursion Pharmaceuticals Inc (RXRX) has experienced a quarterly decline of -29.64% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.42B.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 8.59, with a change in price of -0.82. Similarly, Recursion Pharmaceuticals Inc recorded 5,532,363 in trading volume during the last 100 days, posting a change of -10.98%.
Examining RXRX’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for RXRX stands at 0.12. Similarly, the long-term debt-to-equity ratio is also 0.10.
RXRX Stock Stochastic Average
Today’s raw stochastic average for Recursion Pharmaceuticals Inc over the last 50 days is 42.80%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 60.00%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 67.26% and 68.69%, respectively.
RXRX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The index has shown a price loss of -14.40% this year. Over the last six months, there has been a stronger performance of -28.65%. The price of RXRX fallen by 15.79% during the last 30 days period. For the last 5-days stocks have improved 2.17%.